TBRG
TruBridge, Inc.
$25.94
0.00%
$389.1M
No data for this timeframe.
Vol
Market Cap$389.1M
Cap SizeSmall Cap
Analyst ConsensusSell (0%)
Inst. Holders8 funds
Inst. Value$24.2M
Inst. Activity1 buys / 3 sells
SEC Reports5
Exchange Nasdaq·Sector Services-Computer Programming Services·Inc. DE·CIK 0001169445·Prev Close $25.94
Recent Activity
Apr 23, 2026
SEC
TruBridge, Inc. (TBRG) filed a definitive proxy statement (DEFA14A) to solicit shareholder approval for its acquisition
DEFA14A — Impact 8/10
Apr 23, 2026
SEC
TruBridge, Inc. (TBRG) is being acquired by Inventurus Knowledge Solutions, Inc. (IKS Health) in an all-cash transaction
DEFA14A — Impact 8/10
Apr 23, 2026
SEC
TruBridge, Inc. (TBRG) has entered into a definitive agreement to be acquired by Inventurus Knowledge Solutions, Inc. (P
DEFA14A — Impact 8/10
Apr 8, 2026
Insider
MacIntyre Vita sold 909 shares
Controller @ $0.00 ($0.00)
Apr 8, 2026
Insider
Wilson Merideth sold 5,206 shares
Financial Health GM @ $0.00 ($0.00)
Apr 8, 2026
Insider
Harse David sold 5,079 shares
General Manager Patient Care @ $0.00 ($0.00)
Inst.
MORGAN STANLEY — TRIM
119,834 shares ($2.6M)
Inst.
TWO SIGMA INVESTMENTS, LP — TRIM
55,243 shares ($1.2M)
Price Targets
$25.67
-1.1% upside
Hold
Current $25.94
Low $23.00
Median $26.25
High $26.25
6 analysts
$23.00
$26.25
Analyst Ratings
0Strong Buy
0Buy
8Hold
1Sell
2Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 24, 2026 | Cantor Fitzgerald | DOWNGRADE | Overweight → Neutral |
| Apr 24, 2026 | Freedom Capital Markets | DOWNGRADE | Buy → Hold |
| Apr 1, 2026 | Stephens & Co. | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.68 ▲ +26.4% | $0.68 — $0.68 | 26% YoY | 1 |
| Next Q | $0.79 ▲ +24.2% | $0.79 — $0.79 | -10% YoY | 1 |
| Current FY | $2.87 ▲ +12.7% | $2.78 — $2.95 | 8% YoY | 2 |
| Next FY | $2.97 ▲ +1.6% | $2.85 — $3.15 | 4% YoY | 5 |
Latest Reports
BULLISH
DEFA14A
8/10
TruBridge, Inc. (TBRG) filed a definitive proxy statement (DEFA14A) to solicit shareholder approval for its acquisition
Apr 23, 2026
BULLISH
DEFA14A
8/10
TruBridge, Inc. (TBRG) is being acquired by Inventurus Knowledge Solutions, Inc. (IKS Health) in an all-cash transaction
Apr 23, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $16.4M | — |
| MORGAN STANLEY | $2.6M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $2.4M | ADD |
| TWO SIGMA INVESTMENTS, LP | $1.2M | TRIM |
| RENAISSANCE TECHNOLOGIES LLC | $643.9K | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 8, 2026 | MacIntyre Vita | A | $0.00 |
| Apr 8, 2026 | Wilson Merideth | A | $0.00 |
| Apr 8, 2026 | Harse David | A | $0.00 |
| Apr 8, 2026 | Plessner Kevin | A | $0.00 |
| Apr 8, 2026 | Daughton Michael | A | $0.00 |
8 institutional holders with $24.2M total value (1,094,395 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net selling activity: 3 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 744,705 | $16.4M | 68.0% | — |
| 2 | MORGAN STANLEY | 119,834 | $2.6M | 10.9% | TRIM -33.4% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 107,125 | $2.4M | 9.8% | ADD +35.3% |
| 4 | TWO SIGMA INVESTMENTS, LP | 55,243 | $1.2M | 5.0% | TRIM -55.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 29,176 | $643.9K | 2.7% | NEAR_EXIT -80.5% |
| 6 | BANK OF AMERICA CORP /DE/ | 20,194 | $445.7K | 1.8% | TRIM -57.6% |
| 7 | WELLS FARGO & COMPANY/MN | 10,927 | $241.2K | 1.0% | ADD +78.0% |
| 8 | FMR LLC | 7,191 | $158.7K | 0.7% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 179,833 | 119,834 | -33.4% | $2.6M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 124,856 | 55,243 | -55.8% | $1.2M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 149,651 | 29,176 | -80.5% | $643.9K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 6,138 | 10,927 | +78.0% | $241.2K | 2025-Q4 |
| UBS Group AG | NEAR_EXIT | 237,265 | 32,781 | -86.2% | $661.2K | 2025-Q3 |
| MORGAN STANLEY | ADD | 163,397 | 227,833 | +39.4% | $5.3M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 192,876 | — | $4.5M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 63,735 | 134,960 | +111.8% | $3.2M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 71,572 | 96,820 | +35.3% | $2.3M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 58,334 | 24,723 | -57.6% | $579.0K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 750 | 5,164 | +588.5% | $120.9K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 92,987 | 63,735 | -31.5% | $1.8M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 16,976 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 22,990 | 303,028 | +1218.1% | $6.0M | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 41,111 | 53,088 | +29.1% | $1.0M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 16,976 | — | $334.8K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 73,163 | — | $875.0K | 2024-Q3 |
8 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 8, 2026 | MacIntyre Vita | Controller | A | 909 | $0.00 | $0.00 |
| Apr 8, 2026 | Wilson Merideth | Financial Health GM | A | 5,206 | $0.00 | $0.00 |
| Apr 8, 2026 | Harse David | General Manager Patient Care | A | 5,079 | $0.00 | $0.00 |
| Apr 8, 2026 | Plessner Kevin | General Counsel | A | 2,598 | $0.00 | $0.00 |
| Apr 8, 2026 | Daughton Michael | Chief Business Officer | A | 10,572 | $0.00 | $0.00 |
| Apr 8, 2026 | Bassi Vinay | Chief Financial Officer | A | 12,698 | $0.00 | $0.00 |
| Apr 8, 2026 | Fowler Christopher L | President and CEO | A | 19,683 | $0.00 | $0.00 |
| Mar 27, 2026 | MacIntyre Vita | Controller | F | 187 | $14.07 | $2.6K |
| Mar 16, 2026 | Harse David | General Manager Patient Care | F | 1,098 | $17.59 | $19.3K |
| Mar 16, 2026 | DYE DAVID A | Director | F | 2,793 | $17.59 | $49.1K |
| Mar 16, 2026 | Bassi Vinay | Chief Financial Officer | F | 3,965 | $17.59 | $69.7K |
| Mar 16, 2026 | Fowler Christopher L | President and CEO | F | 5,909 | $17.59 | $103.9K |
| Mar 16, 2026 | Plessner Kevin | General Counsel | F | 825 | $17.59 | $14.5K |
| Mar 13, 2026 | Bassi Vinay | Chief Financial Officer | F | 1,758 | $17.31 | $30.4K |
| Mar 13, 2026 | MacIntyre Vita | Controller | F | 125 | $17.31 | $2.2K |
| Mar 13, 2026 | DYE DAVID A | Director | F | 1,285 | $17.31 | $22.2K |
| Mar 13, 2026 | Fowler Christopher L | President and CEO | F | 2,213 | $17.31 | $38.3K |
| Mar 13, 2026 | Harse David | General Manager Patient Care | F | 571 | $17.31 | $9.9K |
| Mar 13, 2026 | Plessner Kevin | General Counsel | F | 340 | $17.31 | $5.9K |
| Mar 13, 2026 | Wilson Merideth | Financial Health GM | F | 604 | $17.31 | $10.5K |
| Mar 9, 2026 | Plessner Kevin | General Counsel | F | 280 | $18.47 | $5.2K |
| Mar 9, 2026 | Fowler Christopher L | President and CEO | F | 2,093 | $18.47 | $38.7K |
| Mar 9, 2026 | Harse David | General Manager Patient Care | F | 377 | $18.47 | $7.0K |
| Mar 9, 2026 | DYE DAVID A | Director | F | 1,416 | $18.47 | $26.2K |
| Dec 31, 2024 | DYE DAVID A | Director | D | 9,516 | $0.00 | $0.00 |
5 SEC filing reports analyzed. Sentiment: 5 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.8/10.
BULLISH
DEFA14A
8/10
TruBridge, Inc. (TBRG) filed a definitive proxy statement (DEFA14A) to solicit shareholder approval
Apr 23, 2026
BULLISH
DEFA14A
8/10
TruBridge, Inc. (TBRG) is being acquired by Inventurus Knowledge Solutions, Inc. (IKS Health) in an
Apr 23, 2026
BULLISH
DEFA14A
8/10
TruBridge, Inc. (TBRG) has entered into a definitive agreement to be acquired by Inventurus Knowledg
Apr 23, 2026
BULLISH
8-K
7/10
TruBridge, Inc. (TBRG) has entered into a definitive agreement to be acquired by Inventurus Knowledg
Apr 23, 2026
BULLISH
8-K
8/10
TruBridge reported Q4 2025 results with Non-GAAP EPS of $0.79, beating consensus of $0.63 by 25.4%,
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Sell (0% buy). Based on 11 analysts: 0 strong buy, 0 buy, 8 hold, 1 sell, 2 strong sell.
Analyst Price Targets
$25.67 mean target
-1.1% upside
Hold (3.00)
$23.00 Low
$26.25 High
| Metric | Value |
|---|---|
| Current Price | $25.94 |
| Target Low | $23.00 |
| Target Mean | $25.67 |
| Target Median | $26.25 |
| Target High | $26.25 |
| # Analysts | 6 |
| Recommendation | Hold (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.68 | $0.68 | $0.68 | 25.9% | +26.4% | 3↑ 1↓ | $0.1B | 2.4% | 1 |
| Next Q 2026-09-30 |
$0.79 | $0.79 | $0.79 | -10.2% | +24.2% | 4↑ 0↓ | $0.1B | 2.9% | 1 |
| Current FY 2026-12-31 |
$2.87 | $2.78 | $2.95 | 7.7% | +12.7% | 5↑ 0↓ | $0.4B | 1.2% | 2 |
| Next FY 2027-12-31 |
$2.97 | $2.85 | $3.15 | 3.8% | +1.6% | 4↑ 0↓ | $0.4B | 5.6% | 5 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.680 | |
| 7d ago | $0.538 | +0.142 |
| 30d ago | $0.538 | +0.142 |
| 60d ago | $0.472 | +0.208 |
| 90d ago | $0.472 | +0.208 |
3 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 24, 2026 | Cantor Fitzgerald | DOWNGRADE | Overweight | Neutral |
| Apr 24, 2026 | Freedom Capital Markets | DOWNGRADE | Buy | Hold |
| Apr 1, 2026 | Stephens & Co. | MAINTAIN | Equal-Weight | Equal-Weight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 0 | 0 | 8 | 1 | 2 | 0% | |
| Apr 1, 2026 | 2 | 5 | 4 | 0 | 0 | 64% | |
| Mar 1, 2026 | 2 | 5 | 4 | 0 | 0 | 64% | |
| Feb 1, 2026 | 2 | 5 | 4 | 0 | 0 | 64% | |
| Jan 1, 2026 | 2 | 5 | 4 | 0 | 0 | 64% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
TBRG Q1 2026 Earnings Scheduled — 2026-05-13
May 5, 2026
earnings_calendar
TBRG Q1 2026 Earnings Scheduled — 2026-05-05
Apr 13, 2026
short_volume
Short Volume: TBRG — 61.1% short (0.4M / 0.6M)
Short: 356,065 | Exempt: 300 | TRF Vol: 582,688 | Short Ratio: 61.1% | Off-exchange volume (dark pool + OTC)
Mar 16, 2026
earnings_calendar
TBRG Q4 2025 Earnings After Market Close — 2026-03-16